ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984